# OnCo record rec-7735 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rec-7735/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rec-7735" ;
  schema:name "REC-7735"@en ;
  schema:description "REC-7735 is an experimental small molecule, mutant-selective PI3K-alpha inhibitor from Recursion Pharmaceuticals, in phase 1 trials for HR-positive / HER2-negative breast cancer with PIK3CA H1047R and solid tumours."@en ;
  schema:url <https://onco.cc/drugs/rec-7735/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.recursion.com/pipeline>, <https://www.recursion.com/pipeline>, <https://clinicaltrials.gov/search?intr=REC-7735> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule, mutant-selective PI3K-alpha inhibitor" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/pik3ca/> ;
  onco:companies <https://onco.cc/companies/recursion/> ;
  onco:trials <https://onco.cc/trials/nct07819136/> .